Skip to main content

To B or Not to B: B Cell Development and Antibody Responses to EHV-1 in Horses

Student Name: Naya Eady
Student Concentration: Immunology and Infectious Disease
Naya Eady
Principal Investigator: Bettina Wagner
Degree Conferral Date: December 2024
Committee Member 1: Gerlinde Van de Walle
Committee Member 2: John Parker
Committee Member 3: Julia Felippe
Abstract:

In my PhD research, I utilized pre-existing antibodies developed in my laboratory along with a novel IgD antibody, to characterize horse B cell populations in various developmental and immunological states in the peripheral blood. IgD, IgM, and CD23 were used to identify B cell populations earlier in development, while IgG1, IgG4, and CD23 were used to identify mature populations. In the first portion of this dissertation, I delved into the significance of B cell characterization. The sequential research chapters articulated how the incorporation of IgD can be used to better define the B cell profile in the peripheral blood of healthy horses and horses infected with EHV-1, at different stages of development. Lastly, I highlighted two primary antibody isotypes responsible for neutralizing EHV-1 and preventing viral infection, IgG1 and IgG4/7.

Publications:

Eady NA, Holmes C, Schnabel C, Babasyan S, Wagner B. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies. J Virol. 2024 Jun 13;98(6):e0025024. doi: 10.1128/jvi.00250-24. Epub 2024 May 14. PMID: 38742875; PMCID: PMC11237562.